Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age50-80
SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

About this trial

All patients will be completed collection of demographic data, clinical data, and be observed for inflammatory organ damage, oxygenation index or SpO2/ FIO2, WBC, NEU, interleukin-1β, interleukin-6, interleukin-8 (IL-1β/6/8), tumor necrosis factor-α (TNF-α), C-reactive protein (CRP), procalcitonin (PCT), myoglobin (Myo), creatine kinase-MB (CK-MB), high-sensitivity cardiac troponin T (hs-cTnT), neutrophil elastase (NE), myeloperoxidase (MPO), APACHE II score, alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin, Murray lung injury score, serum creatinine, eGFR, mechanical ventilation time, ICU length of stay, drug-related gastrointestinal reactions, and 30-day and 90-day all-cause mortality, among other indicators.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged between 50 and 80 years, male or female;

Patients undergoing elective cardiac surgery;

Have signed the informed consent form (ICF).

Disqualifiers

Patients undergoing emergency surgery;

Patients undergoing deep hypothermic circulatory arrest surgery;

Preoperative predicted mortality >3% according to European System for Cardiac Operative Risk Evaluation II (EuroSCORE II);

Patients undergoing off-pump coronary artery bypass grafting (off-pump CABG) surgery;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Colchicine 0.5 MG

    Drug

    Take 0.5mg of colchicine tablets orally for 3 days before surgery, and continued to take 0.5mg every other day (qod) for 10 days after tracheal extubation.

  • Placebo

    Drug

    Take 0.5mg of starch tablets orally for 3 days before surgery, and continued to take 0.5mg every other day (qod) for 10 days after tracheal extubation.

Treatment groups

768 Participants
are divided into 2 treatment groups
Group A: Experimental group (colchicine group)Experimental treatment 1 intervention
Group B: Control groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Number of Participants with POAF

POAF: Onset of new atrial fibrillation in patients within 10 days post-surgery.

Time frame
postoperative 10 days
2

Number of Participants with PMI

PMI: Patient's high-sensitivity cardiac troponin T (hs-cTnT) exceeds 0.8 ng/L on the first day after surgery, and there is an increase of 10% or more on the second day compared to the first day postoperatively.

Time frame
postoperative 10 days
3

Number of Participants with ARDS

ARDS: Acute Respiratory Distress Syndrome

Time frame
postoperative 10 days
4

Number of Participants with PPS

PPS: post-pericardiotomy syndrome

Time frame
postoperative 10 days

Secondary outcomes

1

Oxygenation index

SpO2 /FIO2

Time frame
postoperative day 1, 3, 5 and 7
2

Inflammatory index

WBC\[×109/L\], Neutrophil\[NEU,%\], Interleukin(IL)-1β\[pg/mL\], IL-6\[pg/mL\], IL-8\[pg/mL\], TNF-α\[pg/mL\], CRP\[mg/L\], PCT\[ng/mL\], neutrophil elastase\[NE,ng/mL\] and myeloperoxidase\[MPO, ng/ml\]

Time frame
postoperative day 1, 3, 5 and 7
3

Myocardial injury marker

myoglobin\[Myo, ng/ml\], CK-MB\[ng/ml\], hs-cTnT\[ng/ml\]

Time frame
postoperative day 1, 3, 5 and 7
4

Acute physiology and chronic health evaluation(APACHE II) socre

Interpretation of APACHE II : minimum 0 and maximum 71; increasing score is associated with an increasing risk of hospital death. acute physiology score, chronic health status score, and age adjustment score

Time frame
postoperative day 1, 3, 5 and 7

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Lead sponsor

First Affiliated Hospital of Zhejiang University

Collaborator

Jinan Central Hospital

Collaborator

The First People's Hospital of Changzhou

Collaborator

Xinhua hospital of ILi in Kazakhstan automomous district

Collaborator

First Affiliated Hospital of Harbin Medical University

Collaborator

Yangzhou University

Collaborator

Shandong Provincial Hospital

Collaborator

Huai'an First People's Hospital

Collaborator

The First Affilated Hospital of the Medical College, Shihezi University

Collaborator

Affiliated Hospital of Nantong University

Collaborator